Skip to content

Drug interactions

Buprenorphine subdermal implant + Mifepristone

Severity: Moderate

Buprenorphine subdermal implant and Mifepristone: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Both drugs have QTc-prolonging potential, so combined use may add to arrhythmia risk. Buprenorphine implant has a low QT effect at its steady exposure.

What this interaction means in plain words

Buprenorphine subdermal implant and Mifepristone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive prolongation of cardiac repolarization; possible CYP3A4 inhibition may raise buprenorphine levels.

What to do

Check an ECG when other risk factors for QT prolongation are present and keep potassium and magnesium normal. Monitor for sedation and respiratory depression.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Buprenorphine subdermal implant and Mifepristone, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Buprenorphine subdermal implant with Mifepristone?

MediHelp rates the interaction as moderate. Buprenorphine subdermal implant and Mifepristone can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Both drugs have QTc-prolonging potential, so combined use may add to arrhythmia risk. Buprenorphine implant has a low QT effect at its steady exposure.

How serious is the interaction between Buprenorphine subdermal implant and Mifepristone?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Check an ECG when other risk factors for QT prolongation are present and keep potassium and magnesium normal. Monitor for sedation and respiratory depression.

What other medicines interact with Mifepristone?

MediHelp also lists interactions of Mifepristone with, for example, Apixaban, Argatroban, Cisapride. The full list is on the Mifepristone page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in